Resumen ejecutivo: Enfermedad por hígado graso no alcohólico en sujetos con diabetes mellitus tipo 2: Postura conjunta de la Asociación Chilena de Hepatología (ACHHEP) y la Sociedad Chilena de Diabetología (SOCHIDIAB)

Simple item page
dc.coverageDOI: 10.4067/S0034-98872021000901360
dc.creatorArab, Juan Pablo
dc.creatorCastro, Lorena
dc.creatorGómez, Patricia C.
dc.creatorVignolo, Paulina
dc.creatorArrese, Marco
dc.creatorBarrera, Francisco
dc.creatorCastro, Fabiola
dc.creatorDíaz, Luis Antonio
dc.creatorDonoso, Anibal
dc.creatorElgueta, Karina
dc.creatorGonzález, Katherine
dc.creatorGonzález, María Isabel
dc.creatorMoreno, Manuel
dc.creatorLazarte, Raúl
dc.creatorPoniachik, Jaime
dc.creatorSalman, Patricio
dc.creatorValderas, Juan Patricio
dc.date2021
dc.date.accessioned2025-11-18T19:56:25Z
dc.date.available2025-11-18T19:56:25Z
dc.description<p>Non-alcoholic fatty liver disease (NAFLD) has a high prevalence and risk of progression to cirrhosis and other complications in patients with type 2 diabetes mellitus (T2DM). Likewise, the presence of NAFLD implies a high risk of developing T2DM, determining a bidirectional relationship between them. The diabetology and hepatology societies, developed a joint initiative aiming to unify criteria, reviewing the definitions, diagnostic criteria, risk stratification, treatment, and follow-up of patients with NAFLD and T2DM. The key questions to be discussed were defined by a panel of specialists in diabetology and hepatology. The Delphi methodology was used to reach consensus on the respective recommendations. Based on the discussion generated among the experts, diagnostic and treatment algorithms were proposed, as well as an indication for referral and the role of the different specialists involved in the management of these patients. Strengthening multidisciplinary work with patients with NAFLD and T2DM will allow the early recognition of the disease, the prevention of the progression to cirrhosis, and reducing the associated complications.</p>eng
dc.identifierhttps://investigadores.uandes.cl/en/publications/708690cb-74fb-4df2-8685-b457852775c6
dc.identifier.urihttps://repositorio.uandes.cl/handle/uandes/59790
dc.languagespa
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcevol.149 (2021) nr.9 p.1360-1371
dc.subjectDiabetes Mellitus, Type 2
dc.subjectFatty Liver
dc.subjectLiver Cirrhosis
dc.subjectNon-alcoholic Fatty Liver Disease
dc.subjectSDG 3 - Good Health and Well-being
dc.titleResumen ejecutivo: Enfermedad por hígado graso no alcohólico en sujetos con diabetes mellitus tipo 2: Postura conjunta de la Asociación Chilena de Hepatología (ACHHEP) y la Sociedad Chilena de Diabetología (SOCHIDIAB)spa
dc.titleNon-alcoholic fatty liver disease in type 2 diabetes: a joint statement of the Chilean Hepatology and Diabetology Societieseng
dc.typeArticleeng
dc.typeArtículospa
Files
Collections
PURE